Accès ouvert

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

Article scientifique 2022 Anglais

Résumé

Citer ce document

Ebong, C., Sserwanga, A., Namuganga, J., Kapisi, J., Mpimbaza, A., Gonahasa, S., Asua, V., Gudoi, S., Kigozi, R., Tibenderana, J., Bwanika, J., Agaba, B., Rubahika, D., Kyabayinze, D., Opigo, J., Rutazana, D., Sebikaari, G., Belay, K., Niang, M., Halsey, E., Moriarty, L., Lucchi, N., Souza, S., Nsobya, S., Kamya, M., Yeka, A. (2022). Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda. https://doi.org/10.1186/s12936-022-04049-1

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Auteur(s)

Chris Ebong Asadu Sserwanga Jane Frances Namuganga James Kapisi Arthur Mpimbaza Samuel Gonahasa Victor Asua Sam Gudoi Ruth Kigozi James Tibenderana John Bosco Bwanika Bosco Agaba Denis Rubahika Daniel Kyabayinze Jimmy Opigo Damian Rutazana Gloria Sebikaari Kassahun Belay Mame Niang Eric S. Halsey Leah F. Moriarty Naomi W. Lucchi Samaly S. Svigel Souza Samuel L. Nsobya Moses R. Kamya Adoke Yeka

Statistiques

Consultations : 1

Téléchargements : 0